**Author details**

Aishat Motolani1 , Matthew Martin1 , Steven Sun1 and Tao Lu1,2,3,4\*

1 Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN, USA

2 Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, USA

3 Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA

4 Experimental and Developmental Therapeutics Program, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN, USA

\*Address all correspondence to: lut@iu.edu

© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

*Repurposing Market Drugs to Target Epigenetic Enzymes in Human Diseases DOI: http://dx.doi.org/10.5772/intechopen.101397*
